According to the result that the enhanced chemotherapeutic response of Cdk2-/- MCA205 cells was not observed in T cell-deficient nu/nu mice, which indicates that, in the context of MTX, inhibition of CDK2 enhances anti-tumor immune responses, which may dependent on host T lymphocytes. Here, CDK2 is linked to neoplasm.